BACKGROUND: Studies on the relationship between complement receptor 1 (CR1) polymorphisms in exon 29 encoding the Knops blood group antigens (Swain-Langley (Sl) and McCoy (McC)) and outcome of clinical malaria have produced inconsistent results. METHODS: Blood samples from Ghanaian children (n = 150) aged 1-12 years with complicated and uncomplicated malaria were genotyped for the Sl and McC blood group alleles by polymerase chain reaction and restriction fragment length polymorphism. Effect of Sl and McC genotypes on the clinical outcome of malaria was evaluated using logistic regression. RESULTS: McCa/b genotype was significantly associated with more than two-fold increased susceptibility for severe malaria (OR = 2.31; 95% CI: 1.03-5.20, P = 0.043). However, McCb/b was associated with an 88% reduced risk of severe malaria (OR = 0.12; 95% CI: 0.02-0.64, P = 0.013). In contrast, there was no significant association between severe malaria and Sl1/1, Sl1/2, Sl2/and McCa/a genotypes. There was a trend towards decreased susceptibility to both cerebral malaria (CM) (OR = 0.13; 95% CI: 0.02-1.15, P = 0.07) and severe malarial anaemia (SA) (OR = 0.14; 95% CI: 0.02-1.19, P = 0.07) for McCb/b genotype when compared with the McCa/a genotype. There were no significant associations between Sl1/2 or Sl2/2 genotype and CM or SA when compared with Sl1/1 genotype. CONCLUSIONS: McCa/b was associated with increased susceptibility to severe malaria and McCb/b associated with reduced risk of severe malaria. Further studies with large sample size in other malaria endemic regions in Africa are warranted to confirm these findings.
BACKGROUND: Studies on the relationship between complement receptor 1 (CR1) polymorphisms in exon 29 encoding the Knops blood group antigens (Swain-Langley (Sl) and McCoy (McC)) and outcome of clinical malaria have produced inconsistent results. METHODS: Blood samples from Ghanaian children (n = 150) aged 1-12 years with complicated and uncomplicated malaria were genotyped for the Sl and McC blood group alleles by polymerase chain reaction and restriction fragment length polymorphism. Effect of Sl and McC genotypes on the clinical outcome of malaria was evaluated using logistic regression. RESULTS:McCa/b genotype was significantly associated with more than two-fold increased susceptibility for severe malaria (OR = 2.31; 95% CI: 1.03-5.20, P = 0.043). However, McCb/b was associated with an 88% reduced risk of severe malaria (OR = 0.12; 95% CI: 0.02-0.64, P = 0.013). In contrast, there was no significant association between severe malaria and Sl1/1, Sl1/2, Sl2/and McCa/a genotypes. There was a trend towards decreased susceptibility to both cerebral malaria (CM) (OR = 0.13; 95% CI: 0.02-1.15, P = 0.07) and severe malarial anaemia (SA) (OR = 0.14; 95% CI: 0.02-1.19, P = 0.07) for McCb/b genotype when compared with the McCa/a genotype. There were no significant associations between Sl1/2 or Sl2/2 genotype and CM or SA when compared with Sl1/1 genotype. CONCLUSIONS:McCa/b was associated with increased susceptibility to severe malaria and McCb/b associated with reduced risk of severe malaria. Further studies with large sample size in other malaria endemic regions in Africa are warranted to confirm these findings.
Authors: J M Moulds; P A Zimmerman; O K Doumbo; L Kassambara; I Sagara; D A Diallo; J P Atkinson; M Krych-Goldberg; R E Hauhart; D E Hourcade; D T McNamara; D J Birmingham; J A Rowe; J J Moulds; L H Miller Journal: Blood Date: 2001-05-01 Impact factor: 22.113
Authors: J M Moulds; L Kassambara; J J Middleton; M Baby; I Sagara; A Guindo; S Coulibaly; D Yalcouye; D A Diallo; L Miller; O Doumbo Journal: Genes Immun Date: 2000-06 Impact factor: 2.676
Authors: Brian O Smith; Rosie L Mallin; Malgorzata Krych-Goldberg; Xuefeng Wang; Richard E Hauhart; Krystyna Bromek; Dusan Uhrin; John P Atkinson; Paul N Barlow Journal: Cell Date: 2002-03-22 Impact factor: 41.582
Authors: J A Rowe; S J Rogerson; A Raza; J M Moulds; M D Kazatchkine; K Marsh; C I Newbold; J P Atkinson; L H Miller Journal: J Immunol Date: 2000-12-01 Impact factor: 5.422
Authors: David J Weatherall; Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo; Climent Casals-Pascual; David J Roberts Journal: Hematology Am Soc Hematol Educ Program Date: 2002
Authors: José A Stoute; Alfred O Odindo; Boaz O Owuor; Erick K Mibei; Malachi O Opollo; John N Waitumbi Journal: J Infect Dis Date: 2003-01-24 Impact factor: 5.226
Authors: Thaisa Lucas Sandri; Selorme Adukpo; Dao Phuong Giang; Christian N Nguetse; Fabiana Antunes Andrade; Hoang van Tong; Nguyen Linh Toan; Le Huu Song; Preetham Elumalai; Kumarasamy Thangaraj; Vijaya Lakshmi Valluri; Francine Ntoumi; Christian G Meyer; Iara Jose de Messias Reason; Peter G Kremsner; Thirumalaisamy P Velavan Journal: PLoS One Date: 2017-05-17 Impact factor: 3.240
Authors: D Herbert Opi; Olivia Swann; Thomas N Williams; J Alexandra Rowe; Alexander Macharia; Sophie Uyoga; Gavin Band; Carolyne M Ndila; Ewen M Harrison; Mahamadou A Thera; Abdoulaye K Kone; Dapa A Diallo; Ogobara K Doumbo; Kirsten E Lyke; Christopher V Plowe; Joann M Moulds; Mohammed Shebbe; Neema Mturi; Norbert Peshu; Kathryn Maitland; Ahmed Raza; Dominic P Kwiatkowski; Kirk A Rockett Journal: Elife Date: 2018-04-25 Impact factor: 8.140